A new drug called Bepirovirsen holds the promise of new advances in the treatment of hepatitis B. The drug, a promising antisense oligonucleotide, is being developed by GSK (GlaxoSmithKline). Phase III data published in May 2026 showed significant functional cure rates (19% in the overall population, 26% in patients with lower viral activity), which could… Read More »
In Naples and on the island of Ischia, the number of hepatitis A cases has risen sharply. According to health authorities, the current number of cases is significantly higher than the average of recent years. To curb the spread of the epidemic, authorities have urged the public to practice strict hygiene. At the same time,… Read More »
The EU-funded TherVacB project is launching a study involving 81 patients to test its experimental therapeutic vaccine against chronic hepatitis B. Unlike prophylactic vaccination, which prevents infection with the hepatitis B virus, this vaccine is only administered after the disease has broken out. The human immune system can successfully eliminate acute hepatitis B virus (HBV)… Read More »
From the newsletter 12/25 of Swiss Hepatitis: The Swiss Hepatitis Symposium 2025, held in Bern, focused on a pressing question: How can we achieve the micro-elimination of viral hepatitis C among people in Opioid Agonist Therapy (OAT), especially in decentralised settings? The symposium emphasised the importance of integrated care models, innovative diagnostic methods, and collaboration… Read More »
By people with HIV/hepatitis, for people with HIV/hepatitis The Positive Council is a specialist committee that represents the interests of people with HIV and hepatitis, as well as those with co-infections. It has particular expertise in the areas of health, law, lobbying and communication. The association consists of people with HIV and/or hepatitis, their relatives… Read More »
INHSU 2025, the 13th International Conference on Health and Hepatitis in Substance Users, is currently taking place in Cape Town. With plenary sessions, interactive workshops, poster and lecture events, panel discussions, film screenings and much more, INHSU 2025 will advocate for the promotion of health equity for people who use drugs. You can expect events… Read More »
The Swiss Hepatitis Symposium 2025 will take place on Monday, 8 December 2025, from 1:30 p.m. to 6:00 p.m. at Welle 7 in Bern. The theme of this year’s symposium is: ‘Viral hepatitis: micro-elimination in people undergoing opioid agonist therapy and substance users’ The symposium will focus on the following topics: – Identifying practical barriers… Read More »
The initiative by the European Centre for Disease Prevention and Control and the European Medicines Agency supports the WHO’s goal of eliminating viral hepatitis as a public health threat by 2030. The guide was published ahead of Prisoners’ Day on 10 August and aims to promote hepatitis B and C prevention and treatment in prisons… Read More »
It’s vacation time and hepatitis A is spreading in Eastern Europe. Cases have also been reported in Germany and Austria. Now is the perfect time to check your vaccination status. Vaccination provides reliable protection against hepatitis A for at least 10 years, sometimes even for life. Booster shots are not usually necessary for healthy individuals.… Read More »
Every year, more than one million people die from hepatitis, and the number continues to rise. Only by working together, raising awareness, and testing and treating more people can we get this disease under control. We have everything we need to eliminate hepatitis by 2030—but the world is falling behind! www.worldhepatitisday.org World-Hepatitis-Day at Hepatitis-Switzerland